Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This workload is handled by 1 distinct examiner, HABTE, KAHSAY, who is responsible for the 1 busiest examiner pending office action. Such a focused portfolio allows for a very specific prosecution approach tailored to 1 examiner history and preferences. The involvement of 1 distinct art unit further narrows the technical scope of the current proceedings.
With only 1 distinct art unit involved, the prosecution risk is concentrated within 1 administrative division. The practitioner does not need to account for varying standards across different units or multiple examiners. The presence of 1 pending office action suggests a narrow engagement with the patent office for this specific technology area. This allows the applicant to focus resources on the specific requirements of 1 distinct examiner to move the application forward. By resolving the 1 busiest examiner pending office action, the applicant can address all current patent office concerns.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HABTE, KAHSAY | 1 | 84.9% | +7.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256804 | CATALYSTS FOR BENZOXAZINE | HABTE, KAHSAY | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18256804 | CATALYSTS FOR BENZOXAZINE | HABTE, KAHSAY | 1624 | §112 | Non-Final OA | — | Pending | Jun 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kahsay Habte has the most, with 1 of LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
